, Manchester, UK,
Ann Hematol. 2010 Jul;89 Suppl 1:11-7. doi: 10.1007/s00277-010-0950-0. Epub 2010 May 7.
Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert Meeting on Consensus and Development of Strategies in ITP, held in Basel on September 3-5, 2009, a group of experts were tasked with reaching a consensus on some frequently asked questions relating to diagnosis and management of children and adults with chronic ITP. The content of this article is designed to provide a practical support to trained haematologists in their care of patients with chronic ITP.
免疫性血小板减少症（ITP）是儿童和成人的一种常见疾病。在新诊断为 ITP 的患者中，治疗策略相对明确。二线治疗则更具争议性，慢性 ITP 的治疗更是如此。在 2009 年 9 月 3 日至 5 日于巴塞尔举行的第三届 ITP 专家会议上，一组专家的任务是就与儿童和成人慢性 ITP 的诊断和管理相关的一些常见问题达成共识。本文的内容旨在为接受过培训的血液学家在照顾慢性 ITP 患者方面提供实用支持。
